Blepharitis – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025
Blepharitis Emerging Therapy and TPP Insights Thelansis’s “Blepharitis Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Blepharitis Overview Blepharitis is a common condition characterized by a chronic inflammatory process of the lid margins and is often caused by dysfunction of the oil glands of the lids and/or secondary to other skin disorders like seborrheic dermatitis and rosacea. It presents with burning sensations and itchiness of the lids and eye irritation due to crust formation around the lid margins and grittiness or irritation of the eyes. It may be anterior or posterior and can also be secondary to other lid and eye disorders like styes and dry eye syndrome. It is diagnosed based on clinical examination of the lid an...